Evidence map›Paper›PMID 30976203›Full record

ArticleCancer cell international2019

Prognostic value of Lin28A and Lin28B in various human malignancies: a systematic review and meta-analysis.

Jiayi Zhang, Aiming Xu, Chenkui Miao, Jie Yang, Min Gu, Ninghong Song

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Lin28/let-7 axis in breast cancer.Molecular biology reports · 2025
    Review
  3. Review
  4. Association ofBiomedicines · 2024
    Article
  5. Article
  6. Article
  7. Role of the RNA-binding protein family in gynecologic cancers.American journal of cancer research · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Disease markers · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Complexity in regulating microRNA biogenesis in cancer.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jiayi Zhang *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 China.
Aiming Xu *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 China.
Chenkui Miao *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 China.
Jie YangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 China.
Min GuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 China.
Ninghong SongDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 China.ORCID 0000-0003-4963-4912
Jiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mammalian homologs of Lin-28, Lin28 (also called Lin28A) and Lin28B, are promising cancer biomarkers. This meta-analysis was performed to evaluate the prognostic values of Lin28A and Lin28B in multiple human malignancies.

methodsSystematic searches of the PubMed, Web of Science and Embase were used to identify relevant studies. Pooled hazard ratios (HRs) with 95% confidence intervals (CI) for overall survival (OS), recurrence-free survival (RFS), disease-free survival (DFS), or progression-free survival (PFS) were respectively calculated.

results3772 Lin28A-associated patients and 1730 Lin28B-related cases were ultimately enrolled in this meta-analysis. The elevated expression level of Lin28A was significantly associated with poor OS (HR = 1.60, P < 0.001) and poor RFS/DFS/PFS (HR = 1.62, P < 0.001) in patients with malignancies. Lin28B overexpression significantly correlated with unfavorable OS (HR = 1.72, P < 0.001) and RFS/DFS/PFS (HR = 2.35, P < 0.001) of human malignancies.

conclusionsLin28A and Lin28B possess significant prognostic values in various human malignancies. Overexpression of Lin28A or Lin28B suggests poor prognosis for cancer patients.

Indexed as

BiomarkerHuman tumorsLin-28Meta-analysisPrognosis

Identifiers

PMID30976203
PMCPMC6444518
OpenAlexW2942383500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.